{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:24:42Z","timestamp":1792103082687,"version":"4.4.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007899","name":"University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007899","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI144722"],"award-info":[{"award-number":["R21AI144722"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI148104"],"award-info":[{"award-number":["P01AI148104"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL007249"],"award-info":[{"award-number":["T32 HL007249"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25HL126140"],"award-info":[{"award-number":["R25HL126140"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 ES007091"],"award-info":[{"award-number":["T32 ES007091"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jaci.2021.11.019","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T01:57:46Z","timestamp":1639101466000},"page":"923-933.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression"],"prefix":"10.1016","volume":"149","author":[{"given":"Vadim","family":"Pivniouk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Pivniouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Uhrlaub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Pivniouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney R.","family":"VanLinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongmin","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peace","family":"Ezeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Churko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayna","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janko","family":"Nikolich-Zugich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-8976","authenticated-orcid":false,"given":"Donata","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2021.11.019_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jaci.2021.11.019_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2021.11.019_bib4","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"183","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2021.11.019_bib5","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.11.019_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jaci.2020.05.004","article-title":"Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells","volume":"146","author":"Kimura","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.019_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib8","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMc2004973","article-title":"Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1","volume":"382","author":"van Doremalen","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2020.03.065","article-title":"Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis","volume":"159","author":"Cheung","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaci.2021.11.019_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2","volume":"383","author":"Puelles","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1056\/NEJMsr2105280","article-title":"SARS-CoV-2 variants and vaccines","volume":"385","author":"Krause","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib12","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1378\/chest.122.6.2042","article-title":"Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study","volume":"122","author":"Schaad","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2021.11.019_bib13","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1378\/chest.119.6.1742","article-title":"Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months","volume":"119","author":"Gutierrez-Tarango","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2021.11.019_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/ACI.0000000000000433","article-title":"Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence","volume":"18","author":"Esposito","year":"2018","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.019_bib15","first-page":"41","article-title":"Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract","volume":"1","author":"Pasquali","year":"2014","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2021.11.019_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188010","article-title":"Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1\/2 mitogen activated protein kinase and cAMP","volume":"12","author":"Roth","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2021.11.019_bib17","doi-asserted-by":"crossref","unstructured":"Pivniouk V, Gimenes JA, Ezeh P, Michael AN, Pivniouk O, Hahn S, et\u00a0al. Airway administration of OM-85, a bacterial lysate, blocks experimental asthma by targeting dendritic cells and the epithelium\/IL-33\/ILC2 axis [Published online ahead of print September 22, 2021. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2021.09.013.","DOI":"10.1016\/j.jaci.2021.09.013"},{"key":"10.1016\/j.jaci.2021.11.019_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1183\/09031936.00103307","article-title":"Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma","volume":"31","author":"Kraft","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2021.11.019_bib19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.jaci.2021.11.019_bib20","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3301731","article-title":"Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods","volume":"9","author":"Sastry","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.jaci.2021.11.019_bib21","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1128\/JVI.73.4.2832-2840.1999","article-title":"Lentivirus vectors using human and simian immunodeficiency virus elements","volume":"73","author":"White","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.jaci.2021.11.019_bib22","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2021.11.019_bib23","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41385-020-00340-z","article-title":"Animal and translational models of SARS-CoV-2 infection and COVID-19","volume":"13","author":"Johansen","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.jaci.2021.11.019_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108959","article-title":"Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2","volume":"35","author":"Dittmar","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.jaci.2021.11.019_bib25","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","article-title":"Inhibition of SARS-CoV-2 by type I and type III interferons","volume":"295","author":"Felgenhauer","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2021.11.019_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jaci.2021.11.019_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100476","article-title":"Enhancing innate immunity against virus in times of COVID-19: trying to untangle facts from fictions","volume":"13","author":"Larenas-Linnemann","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2021.11.019_bib28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fbioe.2020.00545","article-title":"Bacterial lysates as immunotherapies for respiratory infections: methods of preparation","volume":"8","author":"Suarez","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jaci.2021.11.019_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib31","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJMe2103108","article-title":"Interleukin-6 receptor inhibition in Covid-19\u2014cooling the inflammatory soup","volume":"384","author":"Rubin","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib32","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2021.01.024","article-title":"Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia","volume":"147","author":"Pontali","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2021.11.019_bib33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJMoa2101643","article-title":"Tofacitinib in patients hospitalized with Covid-19 pneumonia","volume":"385","author":"Guimaraes","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJMe2034495","article-title":"Monoclonal antibodies to disrupt progression of early Covid-19 infection","volume":"384","author":"Cohen","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib35","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1056\/NEJMoa2102685","article-title":"Bamlanivimab plus etesevimab in mild or moderate Covid-19","volume":"385","author":"Dougan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jaci.2021.11.019_bib37","unstructured":"COVID-19 Vaccine Resource Center. N Engl J Med. Available at: https:\/\/www-nejm-org.ezproxy2.library.arizona.edu\/covid-vaccine. Accessed September 5, 2021."},{"key":"10.1016\/j.jaci.2021.11.019_bib38","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2020-4-14","article-title":"The journey of remdesivir: from Ebola to COVID-19","volume":"9","author":"Pardo","year":"2020","journal-title":"Drugs Context"},{"key":"10.1016\/j.jaci.2021.11.019_bib39","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19\u2014final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2021.11.019_bib40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2021.11.019_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2577-1","article-title":"Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing","volume":"586","author":"Riva","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2021.11.019_bib42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1126\/science.abg5827","article-title":"Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2","volume":"373","author":"Drayman","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.11.019_bib43","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2108728118","article-title":"A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells","volume":"118","author":"Mahoney","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2021.11.019_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jaci.2021.11.019_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13981","article-title":"Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: a meta-analysis","volume":"75","author":"Cao","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaci.2021.11.019_bib46","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jaci.2021.11.019_bib47","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jaci.2021.11.019_bib48","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2021.11.019_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.jaci.2021.11.019_bib50","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1021\/acsnano.0c06836","article-title":"Membrane nanoparticles derived from ACE2-rich cells block SARS-CoV-2 infection","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jaci.2021.11.019_bib51","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14756366.2021.1906663","article-title":"Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor","volume":"36","author":"Li","year":"2021","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.jaci.2021.11.019_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jaci.2021.11.019_bib53","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/v13060953","article-title":"Human immunodeficiency viruses pseudotyped with SARS-CoV-2 spike proteins infect a broad spectrum of human cell lines through multiple entry mechanisms","volume":"13","author":"Xu","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jaci.2021.11.019_bib54","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1002\/jmv.27224","article-title":"Seroprevalence of SARS-CoV-2 antibodies among rural healthcare workers","volume":"93","author":"Neises","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaci.2021.11.019_bib55","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.immuni.2021.05.006","article-title":"SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2","volume":"54","author":"Lu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2021.11.019_bib56","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.cell.2021.05.032","article-title":"An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921025811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674921025811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:03:23Z","timestamp":1777475003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674921025811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0091674921025811"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2021.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}